David M. Mott - 20 Jun 2025 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role: Director
Signature: /s/Mark J. Casey, Attorney-in-Fact
Issuer symbol: NVAX
Transactions as of: 20 Jun 2025
Net transactions value: +$181,853
Form type: 4
Filing time: 24 Jun 2025, 18:40:20 UTC
Previous filing: 23 Jun 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Quoteable Key Fact

"David M. Mott filed Form 4 for NOVAVAX INC (NVAX) on 24 Jun 2025."

Quick Takeaways

This page summarizes David M. Mott's Form 4 filing for NOVAVAX INC (NVAX).
2 reported transactions and 2 derivative rows are listed below.
Filing timestamp: 24 Jun 2025, 18:40.

What Changed

Previous filing in this sequence was filed on 23 Jun 2025.
Current net transaction value: +$181,853.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
MOTT DAVID M	Director	700 QUINCE ORCHARD ROAD, GAITHERSBURG	/s/Mark J. Casey, Attorney-in-Fact	24 Jun 2025	0001219871

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Stock Option (Right to Buy)	Award	$181,853	+28,326		$6.42	28,326	20 Jun 2025	Common Stock	28,326	$6.42	Direct	F3
transaction	NVAX	Restricted Stock Units	Award	$0	+18,884		$0.000000	18,884	20 Jun 2025	Common Stock	18,884		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2	One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.
F3	One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.